Vor Biopharma Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €1.80M
    Gross profit
    -€1.80M
    SG&A expenses
    €27.49M
    R&D expenses
    €287.74M
    EBITDA
    -€313.76M
    D&A
    €3.27M
    EBIT
    -€315.23M
    Interest expenses
    €0.00
    EBT
    -€1.43B
    Tax expenses
    -€771.96K
    Net income
    -€1.43B

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €1.31B
    Changes in working capital
    €6.30M
    Operating cash flow
    -€97.47M
    Capex
    €419.56K
    Other investing cash flow
    €0.00
    Net investing cash flow
    €265.98K
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €197.97M
    Debt repayment
    €0.00
    Other financing cash flow
    €147.75M
    Net financing cash flow
    €195.44M
    Foreign exchange effects
    €0.00
    Net change in cash
    €98.24M
    Cash at end of period
    €165.58M
    Free cash flow
    -€97.05M

    Balance sheet

    Cash and cash equivalents
    €163.51M
    Cash and short-term investments
    €172.08M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €3.74M
    Total current assets
    €175.83M
    Property, plant & equipment
    €20.59K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €360.36K
    Total non-current assets
    €380.95K
    Total assets
    €176.21M
    Accounts payable
    €574.00K
    Short-term debt
    €0.00
    Other current liabilities
    €49.85M
    Total current liabilities
    €50.43M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €1.42B
    Total non-current liabilities
    €1.42B
    Total liabilities
    €1.47B
    Common stock
    €11.15K
    Retained earnings
    -€1.77B
    Other equity
    €12.01K
    Total equity
    -€1.29B
    Total liabilities and shareholders' equity
    €176.21M

    Company information

    Market capitalization
    €112.98M
    Employees
    159
    Enterprise Value
    €8.23M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    110.5% Much better than peer group: -274.4%
    ROA
    -810.4% Much worse than peer group: -48.7%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -86.6%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€8.98M

    Notifications